Status:

COMPLETED

Lymphadenectomy In Ovarian Neoplasms

Lead Sponsor:

Philipps University Marburg

Collaborating Sponsors:

German Research Foundation

Conditions:

Ovarian Cancer

Eligibility:

FEMALE

18-75 years

Phase:

NA

Brief Summary

To assess the efficacy of systematic pelvic and para-aortic lymphadenectomy in patients with advanced ovarian cancer and intra-abdominal complete debulking. Secondary: progression-free survival, comp...

Eligibility Criteria

Inclusion

  • Primary diagnosis of invasive epithelial ovarian cancer FIGO stage IIB-IV (IV only if resectable metastasis in pleura, liver, spleen, and/or abdominal wall)
  • Macroscopic complete resection
  • Age: 18 - 75 years
  • Patients who have given their signed and written informed consent
  • Good performance status (ECOG 0/1)

Exclusion

  • Non epithelial ovarian malignancies and borderline tumors
  • Intraoperative clinically suspicious lymph nodes (bulky nodes)
  • Secondary invasive neoplasms in the last 5 years (except synchronal endometrial carcinoma FIGO IA G1/2, non melanoma skin cancer, breast cancer T1 N0 M0 G1/2) or with any signs of relapse or activity.
  • Recurrent ovarian cancer
  • Prior chemotherapy for ovarian cancer or abdominal/pelvic radiotherapy
  • Diseases of the lymph system (including lymph edema of unknown origin)
  • Clinical relevant dysfunctions of blood clotting (including medicamentous conditioned reasons, e.g. ASS, if not stopped at least 7 days prior to surgery)
  • Any significant medical reasons, age or performance status that will not allow to perform the study procedures (estimation of investigator)
  • Prior retroperitoneal lymph node dissection (systematic or sampling)
  • Pregnancy
  • Dementia or significantly altered mental status that would prohibit the understanding and giving of informed consent
  • Any reasons interfering with regular follow-up

Key Trial Info

Start Date :

December 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2017

Estimated Enrollment :

640 Patients enrolled

Trial Details

Trial ID

NCT00712218

Start Date

December 1 2008

End Date

December 1 2017

Last Update

March 4 2020

Active Locations (59)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 15 (59 locations)

1

Universitaetsklinik Graz

Graz, Austria, 8036

2

Universitaetskliniken LKH Innsbruck

Innsbruck, Austria, 6020

3

AKH Wien

Vienna, Austria, 1090

4

Klinikum Wels-Grieskirchen

Wels, Austria, 4600